Beam Therapeutics BEAM
NASDAQ BEAM
$25.15 -1.87 (-6.92%)
At close: Nov 10, 2026 · 4:00 PM EST

Beam Therapeutics (BEAM) Long-Term Debt Issuances (2019 - 2026)

Updated

Beam Therapeutics' Long-Term Debt Issuances was $93.89 million in Q1 2026.

Analysis

Beam Therapeutics (BEAM) Long-Term Debt Issuances (2019 - 2026) Analysis & Trends

For FY2020, Long-Term Debt Issuances at Beam Therapeutics came in at $3.27 million, down 47.1% from FY2019.

  • In earlier years, Long-Term Debt Issuances was $6.18 million in FY2019.
  • The Q1 2026 figure marks the lowest quarterly Long-Term Debt Issuances since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Beam Therapeutics 2.60 Bn -2.05 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 93.89 Mn
Dec 31, 2020 1.64 Mn
Mar 31, 2020 1.63 Mn
Dec 31, 2019 2.38 Mn
API Access

Beam Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=BEAM&period=max&api_key=YOUR_API_KEY